Rectal cancer does not have a single signature look. What a doctor sees during a colonoscopy can range from a slightly raised bump on the rectal wall to a deep, cratered ulcer or a mass that narrows the passage almost completely. The visual appearance depends heavily on the cancer’s stage, its growth pattern, and whether it started as a polyp that transformed over time. Understanding these different forms helps explain why some tumors are caught early and others are missed, and why conditions like hemorrhoids are sometimes confused with something far more serious.
What Doctors See During a Colonoscopy
When a gastroenterologist looks at the inside of the rectum through a colonoscope, rectal cancers and their precursors show up in several distinct shapes. The international Paris classification, developed by a group of endoscopists, surgeons, and pathologists, provides the standard framework for describing these surface-level growths based on their shape and how much they project into or indent the rectal lining.1Gastrointestinal Endoscopy. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon Using this system, lesions fall into broad categories that any endoscopist worldwide can recognize and communicate about.
Some lesions look like small mushroom-shaped bumps sitting on a stalk (pedunculated polyps), while others are broad-based lumps that bulge from the wall without a stalk (sessile polyps). Still others are almost flat, barely rising above the surrounding mucosa, which makes them particularly easy to overlook. The flatter a lesion is, the harder it is to spot with standard white-light endoscopy, yet flat lesions are not necessarily harmless. In a European study of rectal lesions treated by endoscopic removal, the risk of cancer invading deeper layers was strongly tied to the lesion’s shape: among lesions that were mostly flat but had a slightly depressed center, the invasion rate reached about 59%, while purely flat lesions without depression had a much lower rate.2PubMed. Endoscopic submucosal dissection for early rectal neoplasia: experience from a European center Raised, nodular lesions with nongranular or mixed surfaces also carried a high invasion rate, around 71% in that same study.
The surface texture of a lesion matters as much as its shape. A smooth, glistening surface with a regular pattern usually suggests a benign polyp. When the surface becomes irregular, loses its normal pit pattern, or develops areas that look eroded or discolored, those are red flags that the cells underneath may have turned malignant. Multiple classification systems exist to help endoscopists read these surface clues, including systems that evaluate pit patterns and vascular features visible under specialized lighting.3PubMed Central. Endoscopic Assessment of Colorectal Polyps
The Three Growth Patterns of Established Tumors
Once a rectal cancer moves beyond the early polyp stage and becomes a full-blown tumor, it tends to fall into one of three broad visual categories. A classification adapted from the Japanese system for colorectal cancer simplifies these into protruded, ulcerative, and infiltrative types.4PubMed Central. The prognostic value of tumor macroscopic morphology in colorectal cancer
- Protruded type: The tumor grows inward toward the open channel of the rectum like a bulky mass. It does not tend to burrow downward into the wall or develop an ulcerated crater on its surface. Think of it as a fleshy lump projecting from the wall.
- Ulcerative type: The tumor’s surface is eroded and cratered, often with a raised ridge or rim around its edges. When people imagine what cancer “looks like” inside the body, this is often what they picture. The central ulcer can bleed, which is one reason rectal bleeding is a common symptom.
- Infiltrative type: Instead of growing into the open channel, the tumor invades downward and outward through the rectal wall. It may not have a clearly raised border. Over time, this pattern can narrow the rectal passage significantly, making it harder to pass stool.
These patterns are not just academic labels. The way a tumor grows affects how it behaves and what symptoms it causes. A protruded tumor might cause bleeding earlier because it rubs against passing stool, while an infiltrative one might go unnoticed longer because it spreads outward rather than projecting into the channel. The ulcerative type often produces a mix of bleeding and discomfort. In practice, many tumors show features of more than one type, but the dominant growth pattern still helps clinicians plan the right approach.
How Rectal Cancer Looks Different from Hemorrhoids
This is where things get tricky for patients and, sometimes, for primary care providers. Hemorrhoids and rectal cancer share several symptoms, most notably rectal bleeding, altered bowel habits, and general anorectal discomfort. A systematic review of the overlap between the two conditions found that rectal bleeding was the most common shared symptom, followed by changes in bowel habits and anorectal discomfort.5Dove Press / Journal of Multidisciplinary Healthcare. Hemorrhoids and Rectal Cancer: A Systematic Review of Clinical Overlap, Diagnostic Misclassification, and Early Detection Strategies for Primary Care This overlap leads to frequent misdiagnosis of rectal cancer as hemorrhoids, particularly in settings where endoscopy is not readily available.
Visually, hemorrhoids look quite different from cancer once you are inside the rectum with a scope. Hemorrhoids are engorged, cushion-like vascular structures. They appear as smooth, purplish or bluish swellings, sometimes with visible blood vessels on the surface. They do not have the irregular, friable (easily crumbling), ulcerated texture of a malignant tumor. Externally, hemorrhoids can be felt or seen around the anal opening as soft, sometimes tender swellings. A rectal tumor, by contrast, feels firm or hard on a digital rectal exam, and its surface is typically rough or irregular.
Certain warning signs point toward cancer rather than hemorrhoids. Dark red blood mixed into the stool, rather than bright red blood on the toilet paper or surface of the stool, is more concerning. Persistent anorectal pain that does not come and go with bowel movements, and unexplained weight loss, are additional warning signs that should prompt further investigation.5Dove Press / Journal of Multidisciplinary Healthcare. Hemorrhoids and Rectal Cancer: A Systematic Review of Clinical Overlap, Diagnostic Misclassification, and Early Detection Strategies for Primary Care Major causes of misdiagnosis include clinical inertia, insufficient use of digital rectal examination, and limited access to endoscopy in primary care settings. In other words, the misdiagnosis problem is less about the conditions looking alike under a scope and more about the scope never being used.
Other Conditions That Can Mimic Rectal Cancer on a Scope
Hemorrhoids are the most common false alarm, but they are not the only one. Inflammatory bowel disease, particularly ulcerative colitis and Crohn’s disease, can produce areas of the rectal lining that look angry, ulcerated, and irregular, sometimes mimicking the appearance of early cancer. Colonoscopy is the primary tool for telling these conditions apart. In a study following patients with inflammatory bowel disease over nearly two years, the two main forms could be correctly distinguished at initial diagnosis in about 89% of cases, though in roughly 7% they remained indistinguishable.6Clinical Endoscopy. Differential Diagnosis of Inflammatory Bowel Disease: What Is the Role of Colonoscopy? Severe inflammation makes visual differentiation harder regardless of the underlying cause.
Rectal cancer and anal cancer are also distinct entities despite their proximity. They differ in the type of cells they arise from, their risk factors, how they are staged, and how they are treated.7Radiographics. Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy On imaging or during a physical exam, a mass in the anal canal versus one higher up in the rectum may look superficially similar but has a completely different clinical path. Rectal cancers are staged based on how deep the tumor invades the wall and how many nearby lymph nodes are involved, while anal cancers are staged based on the size of the primary mass and which nodal regions are affected, regardless of how many nodes are positive at each site. Getting the location right is essential for choosing the correct treatment.
What You Might Notice Without a Camera
Most people searching for what rectal cancer looks like are probably not gastroenterologists. They are people who have noticed something unsettling in the bathroom and want to know if it could be serious. The visible signs that a patient can observe at home are limited, but a few deserve attention.
Blood in or on the stool is the symptom that sends most people to the search bar. Rectal cancer bleeding tends to produce blood that is red or dark red, sometimes mixed into the stool rather than just on its surface. Mucus in the stool, particularly if it is blood-tinged, is another sign worth mentioning to a doctor. A feeling of incomplete evacuation, where you feel like you still need to go even after a bowel movement, can result from a mass occupying space in the rectum.
One widely repeated claim deserves correction: the idea that “pencil-thin stool” is a sign of colorectal cancer. A review of the medical literature found that this is a misconception dating back to the late nineteenth century, based on the intuitive but incorrect idea that a tumor narrows the colon and therefore the stool.8PubMed. “Low caliber stool” and “pencil thin stool” are not signs of colo-rectal cancer In reality, stool caliber changes for many reasons, and thin stool by itself is not a reliable indicator of cancer. If thin stool is accompanied by bleeding, pain, or a change in bowel habits that persists for weeks, those accompanying symptoms are what matter, not the stool shape alone.
How Imaging Reveals What the Eye Cannot
Even a skilled endoscopist cannot always tell how far a tumor has spread just by looking at it through a camera. That is where imaging comes in, and each technique shows a different dimension of the cancer’s anatomy.
MRI of the rectum is the workhorse for planning treatment. It shows the tumor’s location and shape, how deep it has grown into the rectal wall, whether it has reached the fascia that wraps around the mesorectum (the fatty tissue surrounding the rectum), and whether nearby lymph nodes look suspicious. It also detects invasion of blood vessels outside the rectal wall.9PubMed Central. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management On MRI, a rectal cancer typically appears as an area of abnormal signal intensity within the rectal wall, disrupting the normal layered structure that healthy rectal tissue shows. Advanced tumors may show irregular borders extending into the surrounding fat.
Endorectal ultrasound provides a close-up view of the rectal wall layers and is particularly good at showing how deep a tumor has grown locally. Multiple studies confirm that endorectal ultrasound is the most accurate modality for assessing how far the tumor has penetrated the wall layers.10PubMed Central. How useful is rectal endosonography in the staging of rectal cancer?11PubMed Central. The role of 3-D endorectal ultrasound in rectal cancer: our experience On ultrasound, the normal rectal wall appears as alternating bright and dark rings. A tumor disrupts these layers, appearing as a dark mass that may extend through one or more rings depending on its depth.
PET/CT adds another dimension by highlighting metabolically active tissue. It is especially valuable for detecting spread beyond the rectum itself, such as metastases in the liver or other distant organs. MRI, meanwhile, tends to be more accurate than CT for evaluating liver metastases specifically.12PubMed Central. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT In practice, doctors often combine these modalities: a colonoscopy to see the surface, MRI to map the local extent, and PET/CT to check for distant spread.
Enhanced Views With Specialized Endoscopy
Standard white-light endoscopy is good, but it has limits. Flat lesions and very early cancers can blend into the surrounding mucosa. That is why several enhanced endoscopy techniques have been developed to make suspicious areas stand out more clearly.
Chromoendoscopy involves spraying dye onto the rectal lining. The dye settles into the grooves and crevices of the mucosa, increasing the visual contrast between normal tissue and irregular areas.13Techniques and Innovations in Gastrointestinal Endoscopy. Chromoendoscopy Techniques in Imaging of Colorectal Polyps and Cancer: Overview and Practical Applications for Detection and Characterization This makes it easier to see the fine pit patterns on a lesion’s surface, which are a key clue to whether the lesion is benign or malignant. It also helps delineate the edges of a lesion more precisely, which matters when planning endoscopic removal.14PubMed Central. Indications, stains and techniques in chromoendoscopy
Narrow-band imaging, or NBI, takes a different approach. Instead of adding dye, it uses filtered light that emphasizes blood vessels and surface patterns. Under NBI, the tiny blood vessels feeding a polyp or tumor become more visible, and their arrangement tells the endoscopist a lot about what is going on underneath. Irregular, chaotic vessel patterns suggest malignancy, while organized, parallel patterns are reassuring. A study combining pit pattern and microvessel features under NBI magnification found that lesions could be graded by their degree of irregularity, helping predict which ones harbored cancer.15PubMed. Characterization of colorectal tumors using narrow-band imaging magnification: combined diagnosis with both pit pattern and microvessel features
Artificial intelligence is entering this space as well. An AI algorithm tested against a dataset of subtle, easily missed polyps detected a significantly higher number than human endoscopists did. The AI achieved about 80% sensitivity for detecting these tricky lesions, compared to roughly 37% for independently credentialed endoscopists and about 12% for trainees.16PubMed. Performance of artificial intelligence for detection of subtle and advanced colorectal neoplasia The gap was especially wide for the most subtle lesions, which are exactly the ones that lead to interval cancers when missed. This technology is not replacing endoscopists, but it is increasingly working alongside them as a real-time second pair of eyes.
What the Rectum Looks Like After Treatment
For people who have been through chemoradiation for rectal cancer, the visual appearance of the treated site becomes critically important. A growing number of patients are being considered for “watch and wait” strategies, where surgery is deferred if the tumor appears to have completely responded to treatment. But judging a complete response requires knowing what a healed rectum looks like versus one with residual cancer hiding underneath a surface that looks almost normal.
A flat, white scar is the most reassuring finding after chemoradiation. In a study evaluating how well endoscopic features predicted a complete response, a flat scar had the highest predictive value, correctly indicating complete response about 70% to 80% of the time.17Annals of Surgery. Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer Small flat ulcers were less reassuring, predicting complete response about 40% to 50% of the time, and large flat ulcers were the least reliable at roughly 29% to 33%. In short, the flatter and more scar-like the area looks, the better the odds that the cancer is truly gone.
Researchers have developed detailed endoscopic criteria for categorizing the post-treatment site as a complete response, near-complete response, or incomplete response. These criteria look at the shape of the scar, the state of any remaining ulcer, the presence of white moss-like tissue, whether any protruding nodules remain, the pit pattern of regenerated tissue at the scar site, and how the rectal wall has changed in terms of flexibility and distensibility.18PubMed. Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy Any residual protruding nodule or recognizable neoplastic pit pattern at the scar site is a sign that cancer cells remain. Magnifying chromoendoscopy, the dye-spraying technique discussed earlier, plays a key role in this assessment because it reveals surface detail that standard endoscopy might miss.
The challenge for patients in a watch-and-wait program is that these assessments need to be repeated regularly. A site that looks like a clean scar at three months can sometimes show regrowth at six or nine months. The visual criteria are good but not perfect, which is why surveillance schedules are intensive, typically involving endoscopy, MRI, and sometimes both, at intervals of a few months during the first couple of years. For the patient, understanding what a reassuring post-treatment rectum looks like versus a concerning one can make those follow-up appointments feel less opaque.
Why So Many Visual Clues Still Require a Biopsy
With all the technology available, from high-definition cameras to AI-powered polyp detectors, you might wonder why doctors still take tissue samples. The answer is that visual appearance can predict cancer with varying accuracy, but it cannot prove it. A lesion that looks benign under NBI might harbor a small focus of cancer within otherwise normal-looking tissue. An ulcer that looks malignant might turn out to be an inflammatory process. The various classification systems are probability tools: they help endoscopists decide what to remove, what to watch, and what demands urgent surgery, but the definitive answer always comes from a pathologist examining the tissue under a microscope.
This matters practically for patients. If your doctor takes a biopsy during a colonoscopy and tells you the area “looks suspicious,” that is an informed visual assessment, not a diagnosis. Conversely, if they say it “looks fine,” that assessment is stronger with enhanced imaging techniques than with white light alone, but it is still not the same as a confirmed negative biopsy. The visual appearance of rectal cancer is the starting point of the diagnostic conversation. It guides decisions, shapes treatment plans, and helps monitor progress after treatment. But it is the combination of what the cancer looks like, how it feels, what imaging reveals about its depth and spread, and what the pathology report says that tells the full story.